Designing innovative therapies for neuropathic pain: Preclinical and early clinical development challenges

Journal of the Peripheral Nervous System

Volumn 19, Issue S2, 2014, Pages S28-S29

  Hoke A ^a   Simpson, D M ^b   Freeman, R ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BIOLOGICAL MARKER;

CONFERENCE PAPER; DISEASE REGISTRY; HUMAN; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NEUROPATHY PATIENT REGISTRY; ACCESS TO INFORMATION; CLASSIFICATION; CLINICAL FEATURE; CLINICAL PROTOCOL; CONFIDENTIALITY; DATA ANALYSIS; DATA PROCESSING; DATA SHARING; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG SCREENING; DRUG TARGETING; EARLY CLINICAL DRUG DEVELOPMENT; EDITORIAL; EXCLUSION CRITERIA; INCLUSION CRITERIA; MEDICAL LITERATURE; MEDICAL RESEARCH; PAIN ASSESSMENT; PAIN INTENSITY; PERIPHERAL NEUROPATHY; PHENOTYPE; PLACEBO EFFECT; PRECLINICAL DRUG DEVELOPMENT; PRIORITY JOURNAL; PUBLICATION;

EID: 84907903146     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/jns.12082     Document Type: Conference Paper

References (0)